309 related articles for article (PubMed ID: 31683923)
1. The
Berry JL; Polski A; Cavenee WK; Dryja TP; Murphree AL; Gallie BL
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31683923
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into RB1 mutation.
Yao Y; Gu X; Xu X; Ge S; Jia R
Cancer Lett; 2022 Oct; 547():215870. PubMed ID: 35964818
[TBL] [Abstract][Full Text] [Related]
3. [Promoting regulated gene diagnosis for retinoblastoma in clinical work].
Liang JH; Zhu XM
Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):806-810. PubMed ID: 31715676
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer molecular analysis of the RB tumor suppressor pathway.
Knudsen ES; Nambiar R; Rosario SR; Smiraglia DJ; Goodrich DW; Witkiewicz AK
Commun Biol; 2020 Apr; 3(1):158. PubMed ID: 32242058
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
Deng X; Iwagawa T; Fukushima M; Watanabe S
Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
[TBL] [Abstract][Full Text] [Related]
7. RB1: a prototype tumor suppressor and an enigma.
Dyson NJ
Genes Dev; 2016 Jul; 30(13):1492-502. PubMed ID: 27401552
[TBL] [Abstract][Full Text] [Related]
8.
Cordier F; Creytens D
J Clin Pathol; 2024 Jun; 77(7):435-438. PubMed ID: 38772617
[No Abstract] [Full Text] [Related]
9. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
[TBL] [Abstract][Full Text] [Related]
10. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
12. Translating RB1 predictive value in clinical cancer therapy: Are we there yet?
Indovina P; Pentimalli F; Conti D; Giordano A
Biochem Pharmacol; 2019 Aug; 166():323-334. PubMed ID: 31176618
[TBL] [Abstract][Full Text] [Related]
13. The human retinoblastoma susceptibility gene (RB1): an evolutionary story in primates.
Viana MC; Tavares WC; Brant AC; Boroni M; Seuánez HN
Mamm Genome; 2017 Jun; 28(5-6):198-212. PubMed ID: 28401291
[TBL] [Abstract][Full Text] [Related]
14. Detection and reporting of RB1 promoter hypermethylation in diagnostic screening.
Price EA; Kolkiewicz K; Patel R; Hashim S; Karaa E; Scheimberg I; Sagoo MS; Reddy MA; Onadim Z
Ophthalmic Genet; 2018 Aug; 39(4):526-531. PubMed ID: 29851531
[TBL] [Abstract][Full Text] [Related]
15. Genetics of Retinoblastoma.
Mallipatna A; Marino M; Singh AD
Asia Pac J Ophthalmol (Phila); 2016; 5(4):260-4. PubMed ID: 27488068
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Information for Known Genetic Carriers of RB1 Pathogenic Variants (Germline and Mosaic).
Reddy MA; Butt M; Hinds AM; Duncan C; Price EA; Sagoo MS; Onadim Z
Ophthalmol Retina; 2021 Apr; 5(4):381-387. PubMed ID: 32835838
[TBL] [Abstract][Full Text] [Related]
17. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing.
Berry JL; Lewis L; Zolfaghari E; Green S; Le BHA; Lee TC; Murphree AL; Kim JW; Jubran R
Ophthalmic Genet; 2018 Jun; 39(3):407-409. PubMed ID: 29286867
[No Abstract] [Full Text] [Related]
18. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459
[TBL] [Abstract][Full Text] [Related]
19. Generation of two H1 hESC sublines carrying deletions of RB1 exon 1/promoter in heterozygous or compound heterozygous state.
Menges J; Cremanns M; Steenpass L
Stem Cell Res; 2019 Aug; 39():101517. PubMed ID: 31404748
[TBL] [Abstract][Full Text] [Related]
20. Molecular alterations in retinoblastoma beyond RB1.
Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
